Allergic rhinitis is a prevalent upper airway inflammatory disease that is especially widespread in the paediatric population. In the medium- to long-term, allergic rhinitis can have a significant impact on quality of life, sleep, and everyday functioning. Watery rhinorrhea, nasal congestion and obstruction, sneezing, and nasal itch are the hallmark clinical manifestations of allergic rhinitis. The diagnosis is based on a thorough history, a chest and nasal examination, and tests for certain immunoglobulin E. Usually, allergic rhinitis coexists with other allergic diseases, including asthma and allergic conjunctivitis. Asthma and allergic rhinitis are prevalent conditions that often coexist. In the literature, this idea has been referred to as a unified airway disease. According to epidemiological research, rhinitis is a common co-occurring condition in most asthma patients, and having rhinitis increases the chance of developing asthma. Patients with rhinitis and asthma have similar physiologies. Avoiding allergens that trigger allergic rhinitis and using pharmacological therapies in accordance with guidelines are essential for its proper management. A tripartite treatment plan incorporating pharmacological treatment, immunotherapy, and environmental control is recommended for the optimal management of allergic rhinitis. However, the sole treatment for the cause is still allergen-specific immunotherapy and various nutraceuticals have been employed for symptomatic relief.